Healthcare -
Biotechnology - NASDAQ - US
$ 4.585
-1.98 %
$ 282 M
Market Cap
-4.55
P/E
GLUE - NET CHANGE IN CASH
Net Change in Cash GLUE - Monte Rosa Therapeutics, Inc.
96.4 M
LAST VALUE
52.68%
2 YEAR CAGR
66.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR